What's Hot

    EveLab Insight Advances Understanding of Skin Aging With AI-Driven Research

    June 5, 2023

    World’s first AI university demonstrates its relevance in global AI talent race with second commencement

    June 5, 2023

    Elevatus Launches EVA-MED: The First Applicant Tracking System for Healthcare Recruitment in the MENA Region

    June 5, 2023
    Facebook Twitter Instagram
    • Home
    • Contact Us
    UAE NewshourUAE Newshour
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    UAE NewshourUAE Newshour
    Home » FDA approved lung cancer drug created by Mirati to cost $19,750 for 180 tablets
    Health

    FDA approved lung cancer drug created by Mirati to cost $19,750 for 180 tablets

    December 13, 2022
    Facebook Twitter Pinterest LinkedIn Tumblr Email

    The US Food and Drug Administration has approved Mirati Therapeutics Inc’s lung cancer drug Adagrasib, according to the company, sending shares of the company up more than 8% in extended trading following the announcement. Mirati’s drug has been approved by the FDA for treating adult patients who are diagnosed with advanced lung cancer based on an FDA-cleared test and who have received at least one previous systemic therapy as determined by the FDA.

    The oral drug Adagrasib targets a mutation in the KRAS gene, which occurs in about 13% of non-small cell lung cancers, the most common form of cancer, and in some other solid tumors less frequently. The drug will be marketed under the brand name Krazati and priced at $19,750 for a 200 milligram tablet and 180 count bottle. Lumakras, a KRAS inhibitor developed by Amgen Inc., is already available for treating patients with advanced lung cancer as second-line therapy after initial treatment has failed.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Ayurveda vs science: Decoding the cold water conundrum

    June 2, 2023

    Big tobacco’s big lie: Philip Morris’ smoke and mirrors strategy

    June 1, 2023

    Unveiling the most overlooked early heart attack symptom

    June 1, 2023

    From crisis to catastrophe: China’s potential 65 million COVID cases per week by June

    May 30, 2023
    Latest News

    EU’s €1.1 billion bicycle exports highlight shift to sustainable living

    June 3, 2023

    Strengthening UAE-India relations: Top diplomats discuss economic partnership

    June 3, 2023

    Ayurveda vs science: Decoding the cold water conundrum

    June 2, 2023

    UN urges immediate action to prevent food and aid crises in cyclone-hit Myanmar

    June 2, 2023

    Big tobacco’s big lie: Philip Morris’ smoke and mirrors strategy

    June 1, 2023

    Unveiling the most overlooked early heart attack symptom

    June 1, 2023

    Sony faces antitrust probe in Romania over PlayStation’s market dominance

    May 31, 2023

    Audio-Technica brings back the Sound Burger: a retro turntable for the modern age

    May 31, 2023

    From crisis to catastrophe: China’s potential 65 million COVID cases per week by June

    May 30, 2023
    © 2022 UAE Newshour | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.